Elevation of pro-inflammatory cytokines, C-reactive protein and cardiac troponin T in chronic renal failure patients on dialysis

Immunological Investigations

Volumn 36, Issue 1, 2007, Pages 47-57

  Wong, C K ^a   Szeto, C C ^a   Chan, M H M ^a   Leung, C B ^a   Li, P K T ^a   Lam, C W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C reactive protein; Cardiac troponin T; Chronic renal failure; Cytokines

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 6; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC VALUE; ELECTROCHEMICAL ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY;

AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; RENAL DIALYSIS; TROPONIN T;

EID: 33845893315     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130600745505     Document Type: Article

References (37)

1. Chiang, C. K., Hsu, S. P., Pai, M. F., Peng, Y. S., Ho, T. I., Liu, S. H., Hung, K. Y., Tsai, T. J. (2004). Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol. Dial. Transplant 19:2810-2815.
2. Chiang, C. K., Hsu, S. P., Pai, M. F., Peng, Y. S., Ho, T. I., Liu, S. H., Hung, K. Y., Tsai, T. J., Hsieh, B. S. (2005). Plasma interleukin-18 levels in chronic renal failure and continuous ambulatory peritoneal dialysis. Blood Purif. 23:144-148.
3. deFilippi, C., Wasserman, S., Rosanio, S., Tiblier, E., Sperger, H., Tocchi, M., Christenson, R., Uretsky, B., Smiley, M., Gold, J., Muniz, H., Badalamenti, J., Herzog, C., Henrich, W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290:353-359.
4. Dinarello, C. A. (1992). Cytokines: agents provocateurs in hemodialysis? Kidney Int. 41:683-694.
5. Duman, D., Tokay, S., Toprak, A., Duman, D., Oktay, A., Ozener, I. C., Unay, O. (2005). Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients. Nephrol. Dial. Transplant 20:962-967.
6. Fernandez-Reyes, M. J., Mon, C., Heras, M., Guevara, P., Garcia, M. C., Sanchez, R., Velasco, S., Alvarez-Ude, F. (2004). Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. J. Nephrol. 17:721-727.
7. Freda, B. J., Tang, W. H., Van Lente, F., Peacock, W. F., Francis, G. S. (2002). Cardiac troponins in renal insufficiency: review and clinical implications. J. Am. Coll. Cardiol. 40:2065-2071.
8. Gangemi, S., Mallamace, A., Minciullo, P. L., Santoro, D., Merendino, R. A., Savica, V, Bellinghieri, G. (2002). Involvement of interleukin-18 in patients on maintenance haemodialysis. Am. J. Nephrol. 22:417-421.
9. Gesualdo, L., Pertosa, G., Grandaliano, G., Schena, F. P. (1998). Cytokines and bioincompatibility. Nephrol. Dial. Transplant 13:1622-1626.
10. Girndt, M., Kohler, H., Schiedhelm-Weick, E., Schlaak, J. F., Meyer zum Buschenfelde, K. H., Fleischer B. (1995). Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int. 47:559-565.
11. Hakim, R. M. (1993). Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 44:484-494.
12. Hocher, B., Schwarz, A., Slowinski, T., Bachmann, S., Pfeilschifter, J., Neumayer, H. H., Bauer, C. (2004). In-vivo interaction of nitric oxide and endothelin. J. Hypertens. 22:111-119.
13. Iliou, M. C., Fumeron, C., Benoit, M. O., Tuppin, P., Calonge, V. M., Moatti, N., Buisson, C., Jacquot, C. (2003). Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am. J. Kidney Dis. 42:513-523.
14. Li, J. J., Chen, J. L. (2005). Inflammation may be a bridge connecting hypertension and atherosclerosis. Med. Hypotheses 64:925-929.
15. Lowbeer, C., Ottosson-Seeberger, A., Gustafsson, S. A., Norrman, R., Hulting, J., Gutierrez, A. (1999). Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol. Dial. Transplant 14:1948-1955.
16. Lowbeer, C., Stenvinkel, P., Pecoits-Filho, R., Heimburger, O., Lindholm, B., Gustafsson, S. A., Seeberger, A. (2003). Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J. Intern. Med. 253:153-160.
17. Memoli, B. (1999). Cytokine production in hemodialysis. Blood Purif. 17:149-158.
18. Memoli, B., Marzano, L., Bisesti, V., Andreucci, M., Guida, B. (1999). Haemodialysis-related lymphomononuclear release of interleukin-12 in patients with end-stage renal disease. J. Am. Soc. Nephrol. 10:2171-2176.
19. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., Fukuda, S., Kurimoto, M. (1996). Interferongamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26:1647-1651.
20. Ohman, E. M., Armstrong, P. W., Christenson, R. H., Granger, C. B., Katus, H. A., Hamm, C. W., O'Hanesian, M. A., Wagner, G. S., Kleiman, N. S., Harrell, F. E. Jr., Califf, R. M., Topol, E. J. (1996). Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N. Engl. J. Med. 335:1333-1341.
21. Panichi, V., Migliori, M., De Pietro, S., Metelli, M. R., Taccola, D., Perez, R., Palla, R., Rindi, P., Cristofani, R., Tetta, C. Plasma C-reactive protein in haemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif. 2000;18:30-36.
22. Panichi, V., Migliori, M., De Pietro, S., Metelli, M. R., Taccola, D., Perez, R., Palla, R., Rindi, P., Cristofani, R., Tetta, C. (2000). Plasma C-reactive protein in hemodialysis patients: a cross-sectional, longitudinal clinical survey. Blood Purif. 18:30-36.
23. Panichi, V., Migliori, M., De Pietro, S., Taccola, D., Bianchi, A. M., Norpoth, M., Metelli, M. R., Giovannini, L., Tetta, C., Palla, R. C. (2001). reactive protein in patients with chronic renal diseases. Ren. Fail. 23:551-562.
24. Panichi, V., Migliori, M., De Pietro, S., Taccola, D., Bianchi, A. M., Giovannini, L., Norpoth, M., Metelli, M. R., Cristofani, R., Bertelli, A. A., Sbragia, G., Tetta, C., Palla, R., Colombo, R. (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron. 91:594-600.
25. Pertosa, G., Grandaliano, G., Gesualdo, L., Schena, F. P. Clinical relevance of cytokine production in hemodialysis. Kidney Int. 2000; 58 (Suppl 76): S104-S111.
26. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., Hennekens, C. H. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:973-979.
27. Rostaing, L., Peres, C., Tkaczuk, J., Charlet, J. P., Bories, P., Durand, D., Ohayon, E., de Preval, C., Abbal, M. (2000). Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic haemodialysis patients. Am. J. Nephrol. 20:18-26.
28. Rostaing, L., Peres, C., Tkaczuk, J., Charlet, J. P., Bories, P., Durand, D., Ohayon, E., Deprival, C., Abbal, M. (2000) Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients. Am. J. Nephrol. 20:18-26.
29. Santoro, A., Mancini, E. (2002). Cardiac effects of chronic inflammation in dialysis patients. Nephrol. Dial. Transplant 17 (Suppl 8):10-15.
30. Scott, B., Deman, A., Peeters, P., Van den Branden, C., Stolear, J. C., Van Camp, G., Verbeelen, D. (2003). Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients. Nephrol. Dial. Transplant 18:737-742.
31. Sester, U., Sester, M., Hauk, M., Kaul, H., Kohler, H., Gimdt, M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol. Dial. Transplant 2000; 15: 1217-1223.
32. Shaldon, S., Lonnemann, G., Koch, K. M. (1987). Cytokine relevance in biocompatibility. Contrib. Nephrol. 79:227-236.
33. Teraoka, S., Mineshima, M., Hoshino, T., Ishimori, I., Kaneko, I., Sato, Y., Haruguchi, H., Agishi, T. (2000). Can cytokines be removed by hemofiltration or hemoadsorption? ASAIO J. 46:448-451.
34. Tetta, C., Camussi, G., Turello, E., Salomone, M., Aimo, G., Priolo, G., Segoloni, G., Vercellone, A. (1990). Production of cytokines in hemodialysis. Blood Purif. 8:337-346.
35. Tripepi, G., Mallamaci, F., Zoccali, C. (2005). Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J. Am. Soc. Nephrol. 16 Suppl 1:S83-S88.
36. Wong, C. K., Ho. C. Y., Li. E. K., Tam, L. S., Lam, C. W. K. (2002). Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 130:345-351.
37. Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., Wanner, C. (1999). Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 55:648-658.